Scarica l'app Stockscreener
4.87
2.79%
-0.14
Dopo l'orario di chiusura:
4.92
0.05
+1.03%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GDRX Giù?
Forum
Previsione
Precedente Chiudi:
$5.01
Aprire:
$5.05
Volume 24 ore:
835.27K
Relative Volume:
0.57
Capitalizzazione di mercato:
$488.46M
Reddito:
$775.09M
Utile/perdita netta:
$-58.68M
Rapporto P/E:
-36.73
EPS:
-0.1326
Flusso di cassa netto:
$64.06M
1 W Prestazione:
-1.02%
1M Prestazione:
-0.61%
6M Prestazione:
+0.62%
1 anno Prestazione:
-44.66%
Intervallo 1D:
$4.83
$5.05
Intervallo di 1 settimana:
$4.83
$5.06
Portata 52W:
$3.675
$9.165
Goodrx Holdings Inc Stock (GDRX) Company Profile
Nome
Goodrx Holdings Inc
Settore
Industria
Telefono
(855) 268-2822
Indirizzo
2701 OLYMPIC BOULEVARD, SANTA MONICA
Confronta GDRX con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GDRX
Goodrx Holdings Inc
|
4.87 | 1.79B | 775.09M | -58.68M | 64.06M | -0.1326 |
|
VEEV
Veeva Systems Inc
|
287.23 | 47.46B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
58.29 | 11.16B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
95.77 | 8.31B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
59.70 | 11.39B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.69 | 6.20B | 906.14M | -52.62M | 89.62M | -0.3621 |
Goodrx Holdings Inc Stock (GDRX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-08-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-05-23 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2024-05-16 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2024-04-10 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-03-25 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2024-03-01 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2024-02-26 | Iniziato | Leerink Partners | Outperform |
| 2024-01-02 | Downgrade | BofA Securities | Buy → Underperform |
| 2023-08-10 | Aggiornamento | DA Davidson | Neutral → Buy |
| 2023-07-31 | Aggiornamento | TD Cowen | Market Perform → Outperform |
| 2022-12-01 | Iniziato | Citigroup | Buy |
| 2022-11-04 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-12 | Iniziato | DA Davidson | Neutral |
| 2022-06-10 | Downgrade | Goldman | Buy → Neutral |
| 2022-06-06 | Ripresa | BofA Securities | Buy |
| 2022-06-01 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2022-05-10 | Downgrade | Evercore ISI | Outperform → In-line |
| 2022-05-10 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-05-10 | Downgrade | Raymond James | Outperform → Mkt Perform |
| 2022-05-10 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-04-11 | Iniziato | Wells Fargo | Equal Weight |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-01 | Ripresa | Credit Suisse | Neutral |
| 2022-03-15 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2022-03-01 | Reiterato | Barclays | Overweight |
| 2022-03-01 | Reiterato | BofA Securities | Neutral |
| 2022-03-01 | Downgrade | Cowen | Outperform → Market Perform |
| 2022-03-01 | Downgrade | Credit Suisse | Outperform → Neutral |
| 2022-03-01 | Reiterato | Evercore ISI | Outperform |
| 2022-03-01 | Reiterato | Goldman | Buy |
| 2022-03-01 | Reiterato | JP Morgan | Underweight |
| 2022-03-01 | Reiterato | RBC Capital Mkts | Outperform |
| 2022-03-01 | Reiterato | SVB Leerink | Outperform |
| 2022-01-07 | Iniziato | Goldman | Buy |
| 2021-12-21 | Iniziato | Stephens | Overweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-08-31 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2021-08-13 | Aggiornamento | Raymond James | Mkt Perform → Outperform |
| 2021-05-28 | Iniziato | Robert W. Baird | Neutral |
| 2021-04-06 | Ripresa | Evercore ISI | Outperform |
| 2021-01-25 | Iniziato | Guggenheim | Buy |
| 2020-11-19 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-11-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-10-19 | Iniziato | Barclays | Equal Weight |
| 2020-10-19 | Iniziato | BofA Securities | Neutral |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-19 | Iniziato | Cowen | Outperform |
| 2020-10-19 | Iniziato | Credit Suisse | Outperform |
| 2020-10-19 | Iniziato | Deutsche Bank | Hold |
| 2020-10-19 | Iniziato | Goldman | Neutral |
| 2020-10-19 | Iniziato | JP Morgan | Neutral |
| 2020-10-19 | Iniziato | Morgan Stanley | Overweight |
| 2020-10-19 | Iniziato | RBC Capital Mkts | Sector Perform |
| 2020-10-19 | Iniziato | SVB Leerink | Outperform |
| 2020-10-19 | Iniziato | UBS | Buy |
Mostra tutto
Goodrx Holdings Inc Borsa (GDRX) Ultime notizie
Published on: 2025-07-29 10:54:56 - metal.it
Amazon Pharmacy Veteran Defects to GoodRx: Inside the Strategic Executive Move Reshaping Digital Health - Stock Titan
What institutional investors are buying GoodRx Holdings Inc. stockExtraordinary performance - jammulinksnews.com
What is the dividend policy of GoodRx Holdings Inc. stockMassive stock growth - jammulinksnews.com
What is GoodRx Holdings Inc. company’s growth strategyHigh-octane financial growth - jammulinksnews.com
What catalysts could drive GoodRx Holdings Inc. stock higher in 2025Access high-yield investment alerts now - jammulinksnews.com
What are the latest earnings results for GoodRx Holdings Inc.Consistently exceptional gains - jammulinksnews.com
How does GoodRx Holdings Inc. generate profit in a changing economyBreakthrough profit margins - jammulinksnews.com
Is GoodRx Holdings Inc. a good long term investmentOver 200% growth - PrintWeekIndia
GoodRx Holdings Inc. Stock Analysis and ForecastRapid capital growth - PrintWeekIndia
What drives GoodRx Holdings Inc. stock priceExceptional earning trajectories - PrintWeekIndia
Exploring High Growth Tech Stocks in the US This July 2025 - simplywall.st
What analysts say about GoodRx Holdings Inc. stockTriple-digit return opportunities - PrintWeekIndia
What institutions are buying GoodRx Holdings Inc. stock nowUnmatched profit potential - jammulinksnews.com
Jim Cramer Holds Back on GoodRx (GDRX) - MSN
Google, Meta Can't Escape GoodRx Health Data Sharing Suit - Law360
OPRX vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - MSN
GOODRX INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of GoodRx Holdings, Inc.GDRX - The Globe and Mail
User - FinancialContent
Is GoodRx Holdings Inc. stock a good hedge against inflationChart Based Entries - Newser
Why GoodRx Holdings Inc. stock attracts strong analyst attentionSolid Return Trade Selections - beatles.ru
OPRX Vs. GDRX: Which Health Tech Stock Has Stronger Revenue Momentum? - Barchart.com
What makes GoodRx Holdings Inc. stock price move sharplyBig Profit Small Risk Alerts - Newser
Goodrx Holdings Inc Azioni (GDRX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Goodrx Holdings Inc Azioni (GDRX) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Spectrum Equity VII, L.P. | 10% Owner |
Jul 03 '25 |
Sale |
4.80 |
10,677 |
51,226 |
0 |
3.88%
0.57%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):